Antibody data
- Antibody Data
- Antigen structure
- References [28]
- Comments [0]
- Validations
- Western blot [1]
- Immunocytochemistry [1]
- Immunohistochemistry [2]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 21129-1-AP - Provider product page
- Provider
- Proteintech Group
- Proper citation
- Proteintech Cat#21129-1-AP, RRID:AB_10695771
- Product name
- KIAA1199 antibody
- Antibody type
- Polyclonal
- Description
- KD/KO validated KIAA1199 antibody (Cat. #21129-1-AP) is a rabbit polyclonal antibody that shows reactivity with human, mouse, rat and has been validated for the following applications: IF, IHC, WB,ELISA.
- Reactivity
- Human, Mouse, Rat
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 20ul, 150ul
Submitted references Lenvatinib induces anticancer activity in gallbladder cancer by targeting AKT.
Altered regulation of DPF3, a member of the SWI/SNF complexes, underlies the 14q24 renal cancer susceptibility locus.
Hypoxia increases KIAA1199/CEMIP expression and enhances cell migration in pancreatic cancer.
Efficacy of hyaluronic acid on intervertebral disc inflammation: An in vitro study using notochordal cell lines and human disc cells.
Deletion of Hyaluronan-Binding Protein Involved in Hyaluronan Depolymerization (HYBID) Results in Attenuation of Osteoarthritis in Mice.
Overexpression of KIAA1199, a novel strong hyaluronidase, is a poor prognostic factor in patients with osteosarcoma.
HYBID derived from tumor cells and tumor-associated macrophages contribute to the glioblastoma growth.
Forced expression of KIAA1199, a novel hyaluronidase, inhibits tumorigenicity of low-grade chondrosarcoma.
A novel metastatic promoter CEMIP and its downstream molecular targets and signaling pathway of cellular migration and invasion in SCLC cells based on proteome analysis.
Serum KIAA1199 is an advanced-stage prognostic biomarker and metastatic oncogene in cholangiocarcinoma.
Implication of HYBID (Hyaluronan-Binding Protein Involved in Hyaluronan Depolymerization) in Hyaluronan Degradation by Synovial Fibroblasts in Patients with Knee Osteoarthritis.
Co-expression of KIAA1199 and hypoxia-inducible factor 1α is a biomarker for an unfavorable prognosis in hepatocellular carcinoma.
Comprehensive histological investigation of age-related changes in dermal extracellular matrix and muscle fibers in the upper lip vermilion.
CEMIP upregulates BiP to promote breast cancer cell survival in hypoxia.
KIAA1199 promotes metastasis of colorectal cancer cells via microtubule destabilization regulated by a PP2A/stathmin pathway.
CEMIP (KIAA1199) induces a fibrosis-like process in osteoarthritic chondrocytes.
KIAA1199 is a secreted molecule that enhances osteoblastic stem cell migration and recruitment.
KIAA1199 overexpression is associated with abnormal expression of EMT markers and is a novel independent prognostic biomarker for hepatocellular carcinoma.
Functional Genomic mRNA Profiling of Colorectal Adenomas: Identification and in vivo Validation of CD44 and Splice Variant CD44v6 as Molecular Imaging Targets.
KIAA1199 promotes migration and invasion by Wnt/β-catenin pathway and MMPs mediated EMT progression and serves as a poor prognosis marker in gastric cancer.
Down-regulation of KIAA1199/CEMIP by miR-216a suppresses tumor invasion and metastasis in colorectal cancer.
KIAA1199 is induced by inflammation and enhances malignant phenotype in pancreatic cancer.
Cochlear Cell Modeling Using Disease-Specific iPSCs Unveils a Degenerative Phenotype and Suggests Treatments for Congenital Progressive Hearing Loss.
KIAA1199/CEMIP/HYBID overexpression predicts poor prognosis in pancreatic ductal adenocarcinoma.
Conditional knockdown of hyaluronidase 2 in articular cartilage stimulates osteoarthritic progression in a mice model.
Distinct Expression Pattern of a Deafness Gene, KIAA1199, in a Primate Cochlea.
Crohn's Disease Fibroblasts Overproduce the Novel Protein KIAA1199 to Create Proinflammatory Hyaluronan Fragments.
Functional proteomic analysis reveals the involvement of KIAA1199 in breast cancer growth, motility and invasiveness.
Ye J, Qi L, Liang J, Zong K, Liu W, Li R, Feng R, Zhai W
Journal of Cancer 2021;12(12):3548-3557
Journal of Cancer 2021;12(12):3548-3557
Altered regulation of DPF3, a member of the SWI/SNF complexes, underlies the 14q24 renal cancer susceptibility locus.
Colli LM, Jessop L, Myers TA, Camp SY, Machiela MJ, Choi J, Cunha R, Onabajo O, Mills GC, Schmid V, Brodie SA, Delattre O, Mole DR, Purdue MP, Yu K, Brown KM, Chanock SJ
American journal of human genetics 2021 Sep 2;108(9):1590-1610
American journal of human genetics 2021 Sep 2;108(9):1590-1610
Hypoxia increases KIAA1199/CEMIP expression and enhances cell migration in pancreatic cancer.
Oba T, Sato N, Adachi Y, Amaike T, Kudo Y, Koga A, Kohi S, Hirata K
Scientific reports 2021 Sep 14;11(1):18193
Scientific reports 2021 Sep 14;11(1):18193
Efficacy of hyaluronic acid on intervertebral disc inflammation: An in vitro study using notochordal cell lines and human disc cells.
Yamamoto T, Suzuki S, Fujii T, Mima Y, Watanabe K, Matsumoto M, Nakamura M, Fujita N
Journal of orthopaedic research : official publication of the Orthopaedic Research Society 2021 Oct;39(10):2197-2208
Journal of orthopaedic research : official publication of the Orthopaedic Research Society 2021 Oct;39(10):2197-2208
Deletion of Hyaluronan-Binding Protein Involved in Hyaluronan Depolymerization (HYBID) Results in Attenuation of Osteoarthritis in Mice.
Momoeda M, de Vega S, Kaneko H, Yoshinaga C, Shimoda M, Nakamura T, Endo Y, Yoshida H, Kaneko K, Ishijima M, Okada Y
The American journal of pathology 2021 Nov;191(11):1986-1998
The American journal of pathology 2021 Nov;191(11):1986-1998
Overexpression of KIAA1199, a novel strong hyaluronidase, is a poor prognostic factor in patients with osteosarcoma.
Ito K, Nishida Y, Ikuta K, Urakawa H, Koike H, Sakai T, Zhang J, Shimoyama Y, Imagama S
Journal of orthopaedic surgery and research 2021 Jul 7;16(1):439
Journal of orthopaedic surgery and research 2021 Jul 7;16(1):439
HYBID derived from tumor cells and tumor-associated macrophages contribute to the glioblastoma growth.
Tsuji S, Nakamura S, Yamada T, de Vega S, Okada Y, Inoue S, Shimazawa M, Hara H
Brain research 2021 Aug 1;1764:147490
Brain research 2021 Aug 1;1764:147490
Forced expression of KIAA1199, a novel hyaluronidase, inhibits tumorigenicity of low-grade chondrosarcoma.
Koike H, Nishida Y, Shinomura T, Zhuo L, Hamada S, Ikuta K, Ito K, Kimata K, Ushida T, Ishiguro N
Journal of orthopaedic research : official publication of the Orthopaedic Research Society 2020 Sep;38(9):1942-1951
Journal of orthopaedic research : official publication of the Orthopaedic Research Society 2020 Sep;38(9):1942-1951
A novel metastatic promoter CEMIP and its downstream molecular targets and signaling pathway of cellular migration and invasion in SCLC cells based on proteome analysis.
Li L, Pan Y, Mo X, Wei T, Song J, Luo M, Huang G, Teng C, Liang K, Mao N, Yang J
Journal of cancer research and clinical oncology 2020 Oct;146(10):2519-2534
Journal of cancer research and clinical oncology 2020 Oct;146(10):2519-2534
Serum KIAA1199 is an advanced-stage prognostic biomarker and metastatic oncogene in cholangiocarcinoma.
Zhai X, Wang W, Ma Y, Zeng Y, Dou D, Fan H, Song J, Yu X, Xin D, Du G, Jiang Z, Zhang H, Zhang X, Jin B
Aging 2020 Nov 10;12(23):23761-23777
Aging 2020 Nov 10;12(23):23761-23777
Implication of HYBID (Hyaluronan-Binding Protein Involved in Hyaluronan Depolymerization) in Hyaluronan Degradation by Synovial Fibroblasts in Patients with Knee Osteoarthritis.
Shiozawa J, de Vega S, Cilek MZ, Yoshinaga C, Nakamura T, Kasamatsu S, Yoshida H, Kaneko H, Ishijima M, Kaneko K, Okada Y
The American journal of pathology 2020 May;190(5):1046-1058
The American journal of pathology 2020 May;190(5):1046-1058
Co-expression of KIAA1199 and hypoxia-inducible factor 1α is a biomarker for an unfavorable prognosis in hepatocellular carcinoma.
Wang D, Lu S, Zhang X, Huang L, Zhao H
Medicine 2020 Dec 11;99(50):e23369
Medicine 2020 Dec 11;99(50):e23369
Comprehensive histological investigation of age-related changes in dermal extracellular matrix and muscle fibers in the upper lip vermilion.
Gomi T, Imamura T
International journal of cosmetic science 2020 Aug;42(4):359-368
International journal of cosmetic science 2020 Aug;42(4):359-368
CEMIP upregulates BiP to promote breast cancer cell survival in hypoxia.
Banach A, Jiang YP, Roth E, Kuscu C, Cao J, Lin RZ
Oncotarget 2019 Jul 2;10(42):4307-4320
Oncotarget 2019 Jul 2;10(42):4307-4320
KIAA1199 promotes metastasis of colorectal cancer cells via microtubule destabilization regulated by a PP2A/stathmin pathway.
Zhao L, Zhang D, Shen Q, Jin M, Lin Z, Ma H, Huang S, Zhou P, Wu G, Zhang T
Oncogene 2019 Feb;38(7):935-949
Oncogene 2019 Feb;38(7):935-949
CEMIP (KIAA1199) induces a fibrosis-like process in osteoarthritic chondrocytes.
Deroyer C, Charlier E, Neuville S, Malaise O, Gillet P, Kurth W, Chariot A, Malaise M, de Seny D
Cell death & disease 2019 Feb 4;10(2):103
Cell death & disease 2019 Feb 4;10(2):103
KIAA1199 is a secreted molecule that enhances osteoblastic stem cell migration and recruitment.
Chen L, Shi K, Andersen TL, Qiu W, Kassem M
Cell death & disease 2019 Feb 12;10(2):126
Cell death & disease 2019 Feb 12;10(2):126
KIAA1199 overexpression is associated with abnormal expression of EMT markers and is a novel independent prognostic biomarker for hepatocellular carcinoma.
Jiang Z, Zhai X, Shi B, Luo D, Jin B
OncoTargets and therapy 2018;11:8341-8348
OncoTargets and therapy 2018;11:8341-8348
Functional Genomic mRNA Profiling of Colorectal Adenomas: Identification and in vivo Validation of CD44 and Splice Variant CD44v6 as Molecular Imaging Targets.
Hartmans E, Orian-Rousseau V, Matzke-Ogi A, Karrenbeld A, de Groot DJ, de Jong S, van Dam GM, Fehrmann RS, Nagengast WB
Theranostics 2017;7(2):482-492
Theranostics 2017;7(2):482-492
KIAA1199 promotes migration and invasion by Wnt/β-catenin pathway and MMPs mediated EMT progression and serves as a poor prognosis marker in gastric cancer.
Jia S, Qu T, Wang X, Feng M, Yang Y, Feng X, Ma R, Li W, Hu Y, Feng Y, Ji K, Li Z, Jiang W, Ji J
PloS one 2017;12(4):e0175058
PloS one 2017;12(4):e0175058
Down-regulation of KIAA1199/CEMIP by miR-216a suppresses tumor invasion and metastasis in colorectal cancer.
Zhang D, Zhao L, Shen Q, Lv Q, Jin M, Ma H, Nie X, Zheng X, Huang S, Zhou P, Wu G, Zhang T
International journal of cancer 2017 May 15;140(10):2298-2309
International journal of cancer 2017 May 15;140(10):2298-2309
KIAA1199 is induced by inflammation and enhances malignant phenotype in pancreatic cancer.
Kohi S, Sato N, Koga A, Matayoshi N, Hirata K
Oncotarget 2017 Mar 7;8(10):17156-17163
Oncotarget 2017 Mar 7;8(10):17156-17163
Cochlear Cell Modeling Using Disease-Specific iPSCs Unveils a Degenerative Phenotype and Suggests Treatments for Congenital Progressive Hearing Loss.
Hosoya M, Fujioka M, Sone T, Okamoto S, Akamatsu W, Ukai H, Ueda HR, Ogawa K, Matsunaga T, Okano H
Cell reports 2017 Jan 3;18(1):68-81
Cell reports 2017 Jan 3;18(1):68-81
KIAA1199/CEMIP/HYBID overexpression predicts poor prognosis in pancreatic ductal adenocarcinoma.
Koga A, Sato N, Kohi S, Yabuki K, Cheng XB, Hisaoka M, Hirata K
Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.] 2017 Jan - Feb;17(1):115-122
Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.] 2017 Jan - Feb;17(1):115-122
Conditional knockdown of hyaluronidase 2 in articular cartilage stimulates osteoarthritic progression in a mice model.
Higuchi Y, Nishida Y, Kozawa E, Zhuo L, Arai E, Hamada S, Morita D, Ikuta K, Kimata K, Ushida T, Ishiguro N
Scientific reports 2017 Aug 1;7(1):7028
Scientific reports 2017 Aug 1;7(1):7028
Distinct Expression Pattern of a Deafness Gene, KIAA1199, in a Primate Cochlea.
Hosoya M, Fujioka M, Okano H, Ogawa K
BioMed research international 2016;2016:1781894
BioMed research international 2016;2016:1781894
Crohn's Disease Fibroblasts Overproduce the Novel Protein KIAA1199 to Create Proinflammatory Hyaluronan Fragments.
Soroosh A, Albeiroti S, West GA, Willard B, Fiocchi C, de la Motte CA
Cellular and molecular gastroenterology and hepatology 2016 May;2(3):358-368.e4
Cellular and molecular gastroenterology and hepatology 2016 May;2(3):358-368.e4
Functional proteomic analysis reveals the involvement of KIAA1199 in breast cancer growth, motility and invasiveness.
Jami MS, Hou J, Liu M, Varney ML, Hassan H, Dong J, Geng L, Wang J, Yu F, Huang X, Peng H, Fu K, Li Y, Singh RK, Ding SJ
BMC cancer 2014 Mar 15;14:194
BMC cancer 2014 Mar 15;14:194
No comments: Submit comment
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- human brain tissue were subjected to SDS PAGE followed by western blot with 21129-1-AP(KIAA1199 antibody) at dilution of 1:500
- Sample type
- tissue
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- Immunofluorescent analysis of HepG2 cells, using KIAA1199 antibody 21129-1-AP at 1:25 dilution and Rhodamine-labeled goat anti-rabbit IgG (red). Blue pseudocolor = DAPI (fluorescent DNA dye).
- Sample type
- cell line
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- Immunohistochemical of paraffin-embedded human stomach cancer using 21129-1-AP(KIAA1199 antibody) at dilution of 1:50 (under 10x lens)
- Sample type
- tissue
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- Immunohistochemical of paraffin-embedded human stomach cancer using 21129-1-AP(KIAA1199 antibody) at dilution of 1:50 (under 40x lens)
- Sample type
- tissue